Lundbeck shakes up executive management team
This article was originally published in Scrip
Lundbeck has reduced its executive management team from six to four, in addition to appointing Marie-Laure Pochon executive vice-president of commercial operations. Ms Pochon remains chief executive of Lundbeck France and regional vice-president for France, Belgium, the UK, Spain, Italy, Turkey and Germany. Peter Andersen and Lars Bang are leaving the executive management team, but will both continue to work in corporate management roles; Mr Andersen has been made senior vice-president of external scientific relation and patents and Mr Bang has been appointed senior vice-president of supply operation and engineering.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.